PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32897609-0	2020	Identification of a novel EHBP1-MET fusion in an intrahepatic cholangiocarcinoma responding to crizotinib.	Crizotinib	95-105	EH domain binding protein 1	Homo sapiens	26-31	
32897609-0	2020	Identification of a novel EHBP1-MET fusion in an intrahepatic cholangiocarcinoma responding to crizotinib.	Crizotinib	95-105	SAFB like transcription modulator	Homo sapiens	32-35	
32897609-7	2020	Subsequently, the patient started treatment with MET inhibitors crizotinib.	Crizotinib	64-74	SAFB like transcription modulator	Homo sapiens	49-52	
32897609-9	2020	To the best of our knowledge, this is the first clinical case report of a MET rearranged-ICC patient successfully treated with crizotinib.	Crizotinib	127-137	SAFB like transcription modulator	Homo sapiens	74-77	
32897609-10	2020	This case suggests that crizotinib may be a promising treatment option for ICC patients with MET fusion, warranting further clinical investigation.	Crizotinib	24-34	SAFB like transcription modulator	Homo sapiens	93-96	
32897609-12	2020	This is also the first clinical case report of clinical benefit from crizotinib treatment in an ICC with MET fusion.	Crizotinib	69-79	SAFB like transcription modulator	Homo sapiens	105-108